In the realm of oncology, the quest for precision medicine has been a longstanding endeavor. Traditional cancer treatments often employed a onesize- fits-all approach, which, while effective for some patients, proved inadequate for many others. However, with advancements in technology and the advent of molecular biomarkers, the landscape of cancer diagnosis and treatment has undergone a transformative shift. Harnessing these molecular signatures has unlocked the potential for tailored therapies, leading to improved outcomes and enhanced patient care. Precision oncology represents a transformative approach to cancer treatment that takes into account the unique molecular characteristics of each patient's tumor. Traditional cancer therapies often relied on a one-size-fits-all approach, but precision oncology aims to personalize treatment strategies based on the specific genetic alterations driving tumor growth. By harnessing molecular biomarkers, clinicians can better understand the underlying biology of cancer and identify targeted therapies that offer the greatest chance of success.
HTML PDFShare this article
Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report
